Yi Larson Turning Point Therapeutics, Inc. (TPTX) insider trading activity

Yi Larson is EVP & Chief Financial Officer of Turning Point Therapeutics, Inc.. Currently has a direct ownership of 7,321 shares of TPTX, which is worth approximately $0. The most recent transaction as insider was on Feb 08, 2021, when has been sold 4,617 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.32K

0% 3M change

0% 12M change

Total Value Held $0

Yi Larson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 08 2021	BUY Grant, award, or other acquisition	-	4,617 Added 38.67%	7,321 Common Stock
Feb 02 2021	SELL Open market or private sale	$1,853,307 $129.62 p/Share	14,298 Reduced 84.1%	2,704 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$772,521 $54.03 p/Share	14,298 Added 45.68%	17,002 Common Stock
Feb 01 2021	SELL Open market or private sale	$1,952,230 $124.33 p/Share	15,702 Reduced 85.31%	2,704 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$848,379 $54.03 p/Share	15,702 Added 46.04%	18,406 Common Stock
Sep 10 2019	BUY Open market or private purchase	$99,990 $45.0 p/Share	2,222 Added 50.0%	2,222 Common Stock

Also insider at

OLMA

Olema Pharmaceuticals, Inc. Healthcare

LIAN

LianBio Healthcare

Chief Financial Officer

RYZB

RayzeBio, Inc.

Yi Larson

EVP & Chief Financial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPTX shares.

Notify only if

Value

Insider Trading

Get notified when an Turning Point Therapeutics, Inc. insider buys or sells TPTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Turning Point Therapeutics, Inc.

Track Activities on TPTX

Account